[WS(P)29] Cell therapy, vaccine, and new therapeutic modality

[WS29-27-P] A novel cell therapy using CCL19-expressing allogeneic mesenchymal stem cells exerts robust anti-tumor effects by accumulating CD103⁺ dendritic cells and priming CD8⁺ T cells without involving draining lymph nodes

^○Yuichi Iida, Mamoru Harada (Department of Immunology, Faculty of Medicine, Shimane University)

キーワード：

Cell therapy、Mesenchymal stem cell、CCL19、Immune check point blockade therapy

閲覧にはパスワードが必要です

ログイン

または